Mesothelioma
Jamie L. Studts, PhD, discusses the use of the QUILS™ system in Kentucky and the importance of community engagement.
Annette McWilliams, MBBS, FRACP, PhD, discusses her IASLC Presidential Symposium presentation on the study.
Jill Feldman, a patient advocate, discusses how the lexicon can improve communication and empower patients.
The KEYNOTE-483 trial showed a significant improvement in OS with the addition of pembrolizumab to chemotherapy.
Martin Reck, MD, PhD, shares his insights on key data in lung cancer to be presented at the ESMO Congress 2024.
Narjust Florez, MD, FASCO, discusses meeting highlights, the IASLC 50th Anniversary Celebration, research, and more.
Researchers used data from the Thoracic Tumors Registry to conduct 2 analyses using artificial intelligence.
The intervention included psychoeducation, relaxation training, and behavioral techniques for managing acute breathlessness.
Eric Singhi, MD, discusses the key milestone that will be celebrated at the conference, which will be held in San Diego.
Learn how clinicians can take practical steps to ensure patients with lung cancer receive comprehensive biomarker testing.
Recent data show that less than half of patients are receiving biomarker testing results before starting treatment.
The study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data in lung cancer.
World Lung Cancer Day is marked on August 1 annually.
The initiative aims to increase biomarker testing rates in communities most impacted by lung cancer disparities.
A pilot study evaluated neoadjuvant platinum, pemetrexed, and nivolumab followed by pleurectomy/decortication.
Nearly 80% of patients enrolled had epithelioid histology and 65% had an ECOG performance status of 1.
Researchers evaluated the combination in an effort to “further enhance the immunogenicity" of the vaccine.
Occupational asbestos exposure leads to shorter survival in patients with malignant mesothelioma.
Guideline-concordant therapy remains underused in most mesothelioma patients.
A complete residential history should be reviewed following a mesothelioma diagnosis.
Radiation therapy with HT is safe and effective in patients with malignant pleural mesothelioma.
Analyzing the exhaled breath of patients with mesothelioma shows tremendous potential as a screening tool.
A simple blood draw could help predict survival outcomes in patients with malignant pleural mesothelioma.
A study assessed the impact of immunotherapy on OS in patients with malignant pleural mesothelioma.
Adoptive cell therapy with autologous TILs was studied to determine its viability as a treatment option for mesothelioma.
Asbestos exposure led to a higher incidence of asbestos-related lung cancers in naval personnel.
BAP1 immunohistochemistry and p16 (CDKN2A) deletion contribute to providing a definitive diagnosis of mesothelioma.
Men and women living with mesothelioma may share similar experiences but have different concerns that nurses and other ...
A qualitative study took a closer look at the experiences of military veterans in the UK living with mesothelioma.
The Food and Drug Administration (FDA) has approved NovoTTF-100L System (Novocure) in conjunction with pemetrexed plus ...
A phase I study presented at the American Association of Clinical Research Annual Meeting showed that chimeric antigen ...
Advertisement
Expert Interviews on Lung Cancer
Advertisement
